Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Oct 03, 2022 12:49pm
208 Views
Post# 35001840

RE:PDFUA

RE:PDFUAClearly, Zip Trader tourists to TH think we should have had a PR already today and still do not realize that whether we do or don't doesn't really matter a ton for the stock. Taimed is likely to receive the news from the FDA but they have a US  office which is where the notification would likely be sent, so the time zone issue is probably not an issue here. 

You notice that TH's stock has not been halted today like drug stocks can be when errally meaningful FDA decisions are imminent. That is probably because this is a not a really meaningful decision.

Also, since it is not critical to anyone's care that the FDA make this decision in a timely fashion and because the FDA is likely overburdened with more important work, the decision could easily be delayed.

Of course, no facts have any merit anyway when the retail tourists led by Zip Trader are dominating the trading. So, the stock may sell of today and then zoom higher tomorrow if the approval does actually come through after the close. And none of that makes any sense at allbut it will still likely happen. 

Biobob wrote: Technically should we have a PR today....


<< Previous
Bullboard Posts
Next >>